Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
23 December 2019
Closing Date:
08 January 2020
Location(s):
PL415 Miasto Poznań (PL Poland/POLSKA)
Description:
Drug delivery as part of chemotherapy and drug programs

1. The subject of the contract is the delivery of medicinal products used in the treatment of hematological diseases and drugs used in the treatment of multiple sclerosis.

2. The description of the subject of the contract containing information about the assortment, quantities and its requirements has been specified in Annex 2 to the ToR constituting its integral part, in which the Ordering Party requires providing the trade name of the drug.

3. The Purchaser allows the submission of partial offers.

4. The order was divided into 10 lots.

5. An offer may be submitted for one or more lots of the contract.

A detailed description of the subject of the contract is included in Annex 2 to the ToR.


Mitomycinum

Description of the subject of the contract containing information about the assortment, quantities and its requirements has been set out in Annex 2 to the ToR constituting its integral part, in which the Ordering Party requires providing the trade name of the drug.


Interferon beta - 1a

Description of the subject of the contract containing information about the assortment, quantities and its requirements has been set out in Annex 2 to the ToR constituting its integral part, in which the Ordering Party requires providing the trade name of the drug.


Dimethylis fumaras

Description of the subject of the contract containing information about the assortment, quantities and its requirements has been set out in Annex 2 to the ToR constituting its integral part, in which the Ordering Party requires providing the trade name of the drug.


Peginterferon beta - 1a

Description of the subject of the contract containing information about the assortment, quantities and its requirements has been set out in Annex 2 to the ToR constituting its integral part, in which the Ordering Party requires providing the trade name of the drug.


natalizumab

Description of the subject of the contract containing information about the assortment, quantities and its requirements has been set out in Annex 2 to the ToR constituting its integral part, in which the Ordering Party requires providing the trade name of the drug.


thiotepa

Description of the subject of the contract containing information about the assortment, quantities and its requirements has been set out in Annex 2 to the ToR constituting its integral part, in which the Ordering Party requires providing the trade name of the drug.

Download full details as .pdf
The Buyer:
Samodzielny Publiczny Zakład Opieki Zdrowotnej Ministerstwa Spraw Wewnętrznych i Administracji w Poznaniu im. prof. Ludwika Bierkowskiego
CPV Code(s):
33600000 - Pharmaceutical products